Investing7d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
With an installed base of over 25,000 sequencing instruments, including more than 21,600 active units as of mid-2024, Illumina has established a strong foothold in the market. The company’s ...
Yahoo Finance5d
Illumina, Inc. (ILMN)
2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export sequencing instruments into China. Illumina respects MOFCOM's decision and will continue to ...
Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race
Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN stock.
Morningstar27d
Illumina's Large Installed System Base Should Insulate It Somewhat From New Entrants
Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...
Business Insider9d
Illumina sees 2025 EPS of $4.50 after China ban, consensus $4.51
Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing instruments into China. Illumina said it “respects ...
Investing7d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
With an installed base of over 25,000 sequencing instruments, including more than 21,600 active units as of mid-2024, Illumina has established a strong foothold in the market. The company’s product ...